Login to Your Account

Pfizer strikes potential $911M deal with Wave Life targeting metabolic disease

By Michael Fitzhugh
Staff Writer

Thursday, May 5, 2016

Wave Life Sciences Ltd. has landed a $40 million up-front payment from Pfizer Inc. in a collaborative deal to develop genetically targeted therapies for metabolic diseases.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription